A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

NCT05907044 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

376

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: RQ3013
BIOLOGICAL: RQ3025
BIOLOGICAL: RQ3027

Sponsor

Affiliated Hospital of Yunnan University

Collaborators

[object Object]
[object Object]